Equate Ranitidine Acid Reducer

Manufacturer
Wal-Mart Stores Inc | Apotex Inc.
Effective date
2016-08-04
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
legacy-cache
Hydrated at
2026-08-02 01:15:56

Label at a glance#

ProductEquate Ranitidine Acid Reducer
Active ingredientRANITIDINE HYDROCHLORIDE
Label structure11 sections

Indications and uses

relieves heartburn associated with acid indigestion and sour stomach prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain foods and beverages

Dosage and administration

adults and children 12 years and over: to relieve symptoms, swallow 1 tablet with a glass of water to prevent symptoms, swallow 1 tablet with a glass of water 30 to 60 minutes before eating food or drinking beverages that cause heartburn can be used up to twice daily (do not take more than 2 tablets in 24 hours) children under 12 years; ask a doctor

Label contents#

Full prescribing information#

SPL PRODUCT DATA ELEMENTS SECTION

SPL UNCLASSIFIED SECTION

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Ranitidine 150 mg (as ranitidine hydrochloride, USP 168 mg)

Purpose

OTC - PURPOSE SECTION

Acid reducer

Uses

INDICATIONS & USAGE SECTION

  • relieves heartburn associated with acid indigestion and sour stomach
  • prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain foods and beverages

Warnings

WARNINGS SECTION

Allergy alert: Do not use if you are allergic to ranitidine or other acid reducers

Do not use

OTC - DO NOT USE SECTION

  • if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor.
  • with other acid reducers
  • if you have kidney disease, except under the advice and supervision of a doctor

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

  • had heartburn over 3 months. This may be a sign of a more serious condition.
  • heartburn with lightheadedness, sweating or dizziness 
  • chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness
  • frequent chest pain  
  • frequent wheezing, particularly with heartburn
  • unexplained weight loss
  • nausea or vomiting
  • stomach pain

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • your heartburn continues or worsens
  • you need to take this product for more than 14 days 

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • adults and children 12 years and over:
    • to relieve symptoms, swallow 1 tablet with a glass of water
    • to prevent symptoms, swallow 1 tablet with a glass of water 30 to 60 minutes before eating food or drinking beverages that cause heartburn
    • can be used up to twice daily (do not take more than 2 tablets in 24 hours)
  • children under 12 years; ask a doctor

Other information

SPL UNCLASSIFIED SECTION

  • do not use if printed foil under bottle cap is broken or torn
  • store at 20°C to 25°C (68°F to 77°F)
  • avoid excessive heat or humidity
  • this product is sodium and sugar free

Inactive ingredients

INACTIVE INGREDIENT SECTION

carnauba wax, colloidal silicon dioxide, ferric oxide red, ferric oxide yellow, hypromellose, magnesium stearate, microcrystalline cellulose, polydextrose, titanium dioxide and vanillin.

Questions or comments?

OTC - QUESTIONS SECTION

1-888-287-1915

Consumer Information

SPL UNCLASSIFIED SECTION

What You Should Know About MAXIMUM STRENGTH Ranitidine Tablets, USP 150 mg

(Please read all of this information before taking MAXIMUM STRENGTH Ranitidine Tablets, USP 150 mg. Save this leaflet for future reference.)

What are MAXIMUM STRENGTH Ranitidine Tablets, USP 150 mg?

• MAXIMUM STRENGTH Ranitidine Tablets, USP 150 mg contains 150 mg of ranitidine (as ranitidine hydrochloride, USP 168 mg), a medicine that doctors have prescribed more than 200 million times worldwide.

Excellent Safety Record

• The ingredient in MAXIMUM STRENGTH Ranitidine Tablets, USP 150 mg, ranitidine has been prescribed by doctors for years to treat millions of patients safely and effectively. The active ingredient in MAXIMUM STRENGTH Ranitidine Tablets, USP 150 mg has been taken safely with many frequently prescribed medications.

• MAXIMUM STRENGTH Ranitidine Tablets, USP 150 mg are sodium and sugar free.

What symptoms does MAXIMUM STRENGTH Ranitidine Tablets, USP 150 mg relieve and prevent?

• MAXIMUM STRENGTH Ranitidine Tablets, USP 150 mg relieves and prevents heartburn associated with acid indigestion and sour stomach.

stomachstomach

• Certain foods or beverages, and even lying down to sleep can cause heartburn associated with acid indigestion and sour stomach. It is normal for the stomach to produce acid, especially after consuming food or beverages. However, acid in the wrong place, such as the esophagus, or too much acid, can cause burning pain and discomfort.

How should I take MAXIMUM STRENGTH Ranitidine Tablets, USP 150 mg?

• To relieve symptoms, swallow 1 tablet with a glass of water.

• To prevent symptoms, swallow 1 tablet with a glass of water 30 to 60 minutes  befo re eating food or drinking beverages that cause heartburn.

• This medicine can be used up to twice daily (do not take more than 2 tablets in 24 hours).

• MAXIMUM STRENGTH Ranitidine Tablets, USP 150 mg should not be given to children under 12 years old unless directed by a doctor.

• Allergy alert: Do not use if you are allergic to ranitidine or other acid reducers.

How does MAXIMUM STRENGTH Ranitidine Tablets, USP 150 mg work?

• MAXIMUM STRENGTH Ranitidine Tablets, USP 150 mg reduce the production of stomach acid. This is what makes MAXIMUM STRENGTH Ranitidine Tablets, USP 150 mg different from antacids, which neutralize the acid already in your stomach. Antacids do not reduce the production of acid.

Tips for managing heartburn

  • Do not lie flat or bend over soon after eating
  • Do not eat late at night, or just before bedtime
  • Certain foods or drinks are more likely to cause heartburn, such as rich, spicy, fatty, and fried foods, chocolate, caffeine, alcohol, even some fruits and vegetables
  • Eat slowly and do not eat big meals
  • If you are overweight, lose weight
  • If you smoke, quit smoking
  • Raise the head of your bed
  • Wear loose fitting clothing around your stomach

When should I see a doctor?

• Do not Use

  • if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor.
  • with other acid reducers
  • if you have kidney disease, except under the advice and supervision of a doctor

• Ask a doctor before use if you have

  • had heartburn over 3 months. This may be a sign of a more serious condition.
  • heartburn with lightheadedness, sweating or dizziness
  • chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness
  • frequent chest pain
  • frequent wheezing, particularly with heartburn
  • unexplained weight loss
  • nausea or vomiting
  • stomach pain

• Stop use and ask a doctor if

  • your heartburn continues or worsens
  • you need to take this product for more than 14 days

• If pregnant or breast-feeding, ask a healthcare professional before use.

• Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Questions? Call 1-888-287-1915

BOTTLES: Bottle is sealed with foil under cap. Do not use if foil is open or torn.

BLISTERS: Do not use if the individual blister unit is open or torn.

Distributed by Wal-Mart

MADE IN CANADA

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

EquateTM

NDC No. 49035-100-06

MAXIMUM STRENGTH

150 mg

Ranitidine Tablets, USP 150 mg

Acid Reducer

  • Prevents and relieves heartburn associated with acid indigestion and sour stomach

65 Tablets

150mg-65tabs150mg-65tabs

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
RANITIDINE HYDROCHLORIDEACTIVE INGREDIENTBK76465IHM3
RANITIDINEACTIVE MOIETY884KT10YB73
CARNAUBA WAXINACTIVE INGREDIENTR12CBM0EIZ3
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61U3
FERRIC OXIDE REDINACTIVE INGREDIENT1K09F3G6753
FERRIC OXIDE YELLOWINACTIVE INGREDIENTEX438O2MRT3
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WO3
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I303
POLYDEXTROSEINACTIVE INGREDIENTVH2XOU12IE3
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU43
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JP3
VANILLININACTIVE INGREDIENTCHI530446X3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
49035-10049035-100-06, 49035-100-07, 49035-100-02, 49035-100-00

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 5 · 253 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4SOLUTION / ORAL336 mgExact identifier — unii candidate
49 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL42 mgExact identifier — unii candidate
40 equally ranked IID candidates
VANILLINVANILLINCHI530446XELIXIR / ORALNAExact identifier — unii candidate
15 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET, ORALLY DISINTEGRATING / ORAL187 mgExact identifier — unii candidate
39 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOJELLY / TOPICALNAExact identifier — unii candidate
27 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4GRANULE, FOR SOLUTION / ORAL1.8 mg/120mlExact identifier — unii candidate
49 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPCAPSULE, COATED, EXTENDED RELEASE / ORALNAExact identifier — unii candidate
40 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675TABLET / BUCCAL0.4 mgExact identifier — unii candidate
21 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30POWDER, FOR SUSPENSION / ORAL120 mgExact identifier — unii candidate
39 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675POWDER, FOR SUSPENSION / ORAL1 mgExact identifier — unii candidate
21 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPGEL / TOPICAL0.06 %w/wExact identifier — unii candidate
40 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPGRANULE, FOR SUSPENSION / ORAL143 mgExact identifier — unii candidate
40 equally ranked IID candidates
CARNAUBA WAXCARNAUBA WAXR12CBM0EIZOINTMENT / TOPICALNAExact identifier — unii candidate
11 equally ranked IID candidates
CARNAUBA WAXCARNAUBA WAXR12CBM0EIZTABLET, FILM COATED / ORAL1 mgExact identifier — unii candidate
11 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675DROPS / ORALNAExact identifier — unii candidate
21 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOGRANULE, FOR SUSPENSION / ORAL1.7 mgExact identifier — unii candidate
27 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UTABLET, CHEWABLE, EXTENDED RELEASE / ORAL144 mgExact identifier — unii candidate
28 equally ranked IID candidates
FERRIC OXIDE YELLOWFERRIC OXIDE YELLOWEX438O2MRTTABLET, DELAYED RELEASE / ORAL7 mgExact identifier — unii candidate
20 equally ranked IID candidates
CARNAUBA WAXCARNAUBA WAXR12CBM0EIZTABLET, DELAYED RELEASE / ORAL230 mgExact identifier — unii candidate
11 equally ranked IID candidates
FERRIC OXIDE YELLOWFERRIC OXIDE YELLOWEX438O2MRTTABLET, ORALLY DISINTEGRATING / ORAL2 mgExact identifier — unii candidate
20 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPLOTION / TOPICALNAExact identifier — unii candidate
40 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPSUSPENSION / ORAL113 mgExact identifier — unii candidate
40 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4POWDER, FOR SUSPENSION / ORAL2553 mgExact identifier — unii candidate
49 equally ranked IID candidates
FERRIC OXIDE YELLOWFERRIC OXIDE YELLOWEX438O2MRTCAPSULE, EXTENDED RELEASE / ORAL7 mgExact identifier — unii candidate
20 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPCAPSULE / ORAL72 mgExact identifier — unii candidate
40 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675LOTION / TOPICALNAExact identifier — unii candidate
21 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET, COATED / ORAL184 mgExact identifier — unii candidate
39 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30CAPSULE / ORAL256.4 mgExact identifier — unii candidate
39 equally ranked IID candidates
FERRIC OXIDE YELLOWFERRIC OXIDE YELLOWEX438O2MRTTABLET / ORAL24 mgExact identifier — unii candidate
20 equally ranked IID candidates
FERRIC OXIDE YELLOWFERRIC OXIDE YELLOWEX438O2MRTPOWDER, FOR SUSPENSION / ORAL3 mgExact identifier — unii candidate
20 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPCAPSULE, COATED / ORAL17 mgExact identifier — unii candidate
40 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4DROPS / ORALNAExact identifier — unii candidate
49 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOTABLET, EXTENDED RELEASE / ORAL1472 mgExact identifier — unii candidate
27 equally ranked IID candidates
POLYDEXTROSEPOLYDEXTROSEVH2XOU12IETABLET, FILM COATED / ORAL18 mgExact identifier — unii candidate
3 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET, FILM COATED, EXTENDED RELEASE / ORAL53 mgExact identifier — unii candidate
39 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPCAPSULE, LIQUID FILLED / ORAL12 mgExact identifier — unii candidate
40 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675CAPSULE, DELAYED RELEASE / ORAL14 mgExact identifier — unii candidate
21 equally ranked IID candidates
FERRIC OXIDE YELLOWFERRIC OXIDE YELLOWEX438O2MRTTABLET / BUCCAL1 mgExact identifier — unii candidate
20 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOCAPSULE, EXTENDED RELEASE / ORAL119.7 mgExact identifier — unii candidate
27 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30CAPSULE, EXTENDED RELEASE / ORAL117 mgExact identifier — unii candidate
39 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOSUSPENSION / ORAL305 mgExact identifier — unii candidate
27 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4GRANULE, FOR SUSPENSION / ORAL200 mgExact identifier — unii candidate
49 equally ranked IID candidates
FERRIC OXIDE YELLOWFERRIC OXIDE YELLOWEX438O2MRTTABLET, COATED / ORAL1 mgExact identifier — unii candidate
20 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4FILM, EXTENDED RELEASE / TRANSDERMAL49 mgExact identifier — unii candidate
49 equally ranked IID candidates
CARNAUBA WAXCARNAUBA WAXR12CBM0EIZTABLET, EXTENDED RELEASE / ORAL2150 mgExact identifier — unii candidate
11 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET / SUBLINGUAL17.5 mgExact identifier — unii candidate
39 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UCAPSULE / ORAL2169 mgExact identifier — unii candidate
28 equally ranked IID candidates
FERRIC OXIDE YELLOWFERRIC OXIDE YELLOWEX438O2MRTGRANULE, FOR SUSPENSION / ORAL11 mgExact identifier — unii candidate
20 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30SUSPENSION / ORAL64 mgExact identifier — unii candidate
39 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPCAPSULE, EXTENDED RELEASE / ORAL67 mgExact identifier — unii candidate
40 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOTABLET, FILM COATED, EXTENDED RELEASE / ORAL221 mgExact identifier — unii candidate
27 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30RING / VAGINAL2 mgExact identifier — unii candidate
39 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET, CHEWABLE / ORAL254 mgExact identifier — unii candidate
49 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPSOAP / TOPICAL1 %w/wExact identifier — unii candidate
40 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30POWDER / RESPIRATORY (INHALATION)0.13 mgExact identifier — unii candidate
39 equally ranked IID candidates
VANILLINVANILLINCHI530446XSOLUTION / ORAL2.5 mg/5mlExact identifier — unii candidate
15 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOTABLET, COATED / ORAL58 mgExact identifier — unii candidate
27 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET, EXTENDED RELEASE / ORAL450 mgExact identifier — unii candidate
49 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4GEL / DENTAL19 %w/wExact identifier — unii candidate
49 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4CAPSULE, COATED PELLETS / ORAL69 mgExact identifier — unii candidate
49 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A200172-001RANITIDINE HYDROCHLORIDERANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-31

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 44 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-10-15 13:18:302026-09A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-31c2088c7a36db…
2026-09-14 22:38:342026-08A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-3184e616aacf4f…
2026-08-18 06:07:402026-07A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-31caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-31011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-3131067a03dcf5…
2025-08-23 18:47 UTC2025-08A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-316a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-31fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-31b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-3103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-312680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-315bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-31d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-31d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-3179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-31301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-311e350fbaab3a…
2024-05-31 18:47 UTC2024-05A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-318072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-315c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-315d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-314b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-3174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-31bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-31782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-3187673890dc5c…
2021-03-12 10:30 UTC2021-03A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-315aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-318869cabd3fbd…
2020-11-12 02:37 UTC2020-11A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-31c0c555d07b60…
2019-12-14 00:12 UTC2019-12A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-313f01610625f2…
2019-09-15 20:21 UTC2019-09A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-31b00525d2431f…
2019-07-19 19:46 UTC2019-07A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-31ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-316a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-311c564ffb4f44…
2023-12-20 04:57 UTC2023-12A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-31ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-31a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-319b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-31a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-313f0d92c62455…
2023-05-13 08:27 UTC2023-05A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-31053a50430f4f…
2023-01-26 05:58 UTC2023-01A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-313bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A200172-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2012-05-313a93d1ddd44b…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
75898ab2-b73f-04a0-ed58-11ff2e1c82642e48e312-9e8a-a251-fc22-9ce6d3e6bd2f2019-11-19WarningsExact identifier
spl set id: 2e48e312-9e8a-a251-fc22-9ce6d3e6bd2f

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.